<DOC>
	<DOCNO>NCT01953081</DOCNO>
	<brief_summary>This study conduct evaluate safety , tolerability early efficacy IV TD 8954 compare metoclopramide critically ill subject , age 18 85 year , admit intensive care require mechanical ventilation , intolerant enteral feeding .</brief_summary>
	<brief_title>A Randomized , Double-Blind Study Evaluate Safety , Tolerability , Pharmacodynamics Single Dose Intravenous TD-8954 Compared With Metoclopramide Critically Ill Patients With Enteral Feeding Intolerance</brief_title>
	<detailed_description />
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Metoclopramide</mesh_term>
	<criteria>Intubated , mechanical ventilation , anticipate remain mechanical ventilation 2 day enrollment study Receiving enteral feeding assess developed EFI , define GRV measurement â‰¥250 mL within 24 hour randomization History diabetic idiopathic gastroparesis Screening blood glucose &gt; 15 mmol/L ( 270 mg/dL ) receive insulin Impaired renal function , define estimate glomerular filtration rate ( eGFR ) &lt; 30 mL/min , determine CockcraftGault formula Bilirubin concentration blood &gt; 2 time upper limit normal ALT AST &gt; 3 time upper limit normal Alkaline phosphatase &gt; 2 time upper limit normal Contraindication enteral feeding Opioid drug overdose primary reason admission Intensive Care Unit ( ICU ) Receipt drug use gastric prokinetic agent Receipt agent know directly influence 5 HT4/acetylcholine prokinetic mechanism</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Enteral feeding</keyword>
</DOC>